Navigation Links
The MaxCyte(R) STX(TM) Scalable Transfection System to be Presented at the Rapid Fire Innovation Session at LabAutomation2009

GAITHERSBURG, Md., Jan. 26 /PRNewswire/ -- MaxCyte, Inc., the pioneer in scalable, high performance cell loading systems, announces the presentation of the MaxCyte(R) STX(TM) Scalable Transfection System at LabAutomation2009 in the Rapid Fire Innovation Session, a joint program of the Association for Laboratory Automation (ALA) and the Laboratory Robotics Interest Group (LRIG). The Rapid Fire Innovation Session showcases the latest innovations in laboratory automation and technology products and services. The presentation will take place Monday evening, January 26, at 7:00PM, at LabAutomation2009 in Palm Springs, CA.

"The Rapid-Fire Innovation Session at LabAutomation2009 provides an opportunity for scientists and engineers to learn about innovative technologies that can enhance and improve the capabilities and productivity of R&D labs," says Dr. Karen Donato, Vice President of Sales and Marketing, who will be presenting the MaxCyte STX technology in the session. "The selection of the MaxCyte STX for this session attests to the uniqueness of MaxCyte's large scale transfection technology. Using the MaxCyte STX, more than ten billion cells can be transfected in less than 30 minutes with one or more loading agents at efficiencies and cell viabilities often exceeding 90%. The speed, scale, and flexibility of our technology allow the development of an expanded range of relevant cell-based assays for drug discovery. We are pleased to have the opportunity to present and demonstrate the MaxCyte STX technology at LabAutomation2009."

"The MaxCyte STX is being viewed by the pharmaceutical industry as an innovative and enabling technology for cell modification for both research and large scale cell-based applications in drug discovery," says MaxCyte President and CEO, Doug Doerfler. "The MaxCyte STX can produce billions of high quality transfected cells in minutes compared to time consuming and inconsistent alternative methods. With the infinite number of combinations of cell types and loading agents that can be processed reproducibly with the MaxCyte STX, drug discovery scientists now have a powerful tool for modifying cells in ways that will improve the design, development, and conduct of screening assays, increasing the likelihood of finding successful drug candidates."

MaxCyte will also be participating in LabAutomation2009 as an exhibitor and offering demonstrations of the MaxCyte STX during the conference.

About MaxCyte

MaxCyte specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of innovative therapeutic products. Drawing on its cell therapy expertise, MaxCyte has designed the MaxCyte(R) STX(TM) Scalable Transfection System expressly for rapid, scalable, and reagent-free cell transfection for cell based assays, preclinical protein production, and other cellbased applications.

For more information,

SOURCE MaxCyte, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. MaxCyte Debuts the STX Scalable Transfection System at the A/C/T Assays & Cellular Targets Meeting
2. The MaxCyte STX Scalable Transfection System to be Launched at the SBS Symposium on Cell-Based Assays
3. Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types
4. Altogen Biosystems Launches Custom Biotechnology Research Services: Generation of Stable Cell Lines and RNAi Cell Transfection Services
5. Senesco Signs a Supply Agreement for Polyplus-transfections Delivery System
6. Altogen Biosystems Launches New Nanoparticle-based In Vivo Transfection Reagent
7. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
8. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
9. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
10. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
11. Actavis Receives Approval of Fentanyl Transdermal System in the U.S.
Post Your Comments:
(Date:6/23/2016)... Wausau, WI (PRWEB) , ... June 23, 2016 ... ... probiotic supplements, is pleased to announce the launch of their brand, UP4™ Probiotics, ... supplements for over 35 years, is proud to add Target to its list ...
(Date:6/23/2016)... June 23, 2016 A person commits a crime, ... scene to track the criminal down. An outbreak ... and Drug Administration (FDA) uses DNA evidence to track down ... Sound far-fetched? It,s not. The FDA has increasingly used ... investigations of foodborne illnesses. Put as simply as possible, whole ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... launch of the Supplyframe Design Lab . Located in Pasadena, Calif., the ... future of how hardware projects are designed, built and brought to market. , ...
Breaking Biology Technology:
(Date:5/9/2016)... Elevay is currently known as ... for high net worth professionals seeking travel for work ... world, there is still no substitute for a face-to-face ... your deal with a firm handshake. This is why ... of citizenship via investment programs like those offered by ...
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
(Date:4/19/2016)... 20, 2016 The new GEZE ... compact web-based "all-in-one" system solution for all door components. ... or the door interface with integration authorization management system, ... systems. The minimal dimensions of the access control and ... building installations offer considerable freedom of design with regard ...
Breaking Biology News(10 mins):